Atkins Michael B.
SEC insider (Form 3/4/5 filer). CIK 0002004793. Director at Werewolf Therapeutics, Inc. (HOWL). 1 reported Form 4/5 transaction since Sep 2024; latest on Jun 12, 2025. Located in WATERTOWN, MA.
Companies Atkins Michael B. has filed insider reports for
- Werewolf Therapeutics, Inc. (HOWL): Director
Atkins Michael B.
CIK: 0002004793
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
HOWL
Werewolf Therapeutics, Inc.
Director